Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4Thoracic 3Gastrointestinal 3CNS 3Head & Neck 2Genitourinary 2Gynecologic 1

Conditions

Ovarian Neoplasms 359Endometrial Neoplasms 207Uterine Cervical Neoplasms 187Breast Neoplasms 109Fallopian Tube Neoplasms 96Colorectal Neoplasms 83Carcinoma, Non-Small-Cell Lung 76Neoplasms 65Pancreatic Neoplasms 59Stomach Neoplasms 55Neoplasm Metastasis 51Prostatic Neoplasms 50Lung Neoplasms 46Melanoma 43Carcinoma, Ovarian Epithelial 41Triple Negative Breast Neoplasms 38Squamous Cell Carcinoma of Head and Neck 36Esophageal Neoplasms 35Carcinoma, Renal Cell 35Colonic Neoplasms 31Urinary Bladder Neoplasms 30Peritoneal Neoplasms 29Head and Neck Neoplasms 28Vulvar Neoplasms 26Uterine Neoplasms 26Carcinoma, Hepatocellular 26Carcinoma, Transitional Cell 24Small Cell Lung Carcinoma 23Sarcoma 20Rectal Neoplasms 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Margins of Excision × Gynecologic × 90 days × Clear all
NCT07517198 2026-04-08

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Exscientia AI Limited

Phase 1 Recruiting
40 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Liver Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡